Adenosine: A key effector molecule of asthma or just another mediator?

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 282, Issue 2 26-2, 2002, Pages

  Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; CATHEPSIN; COMPLEMENTARY DNA; ENPROFYLLINE; FIBRONECTIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 5; OSTEOPONTIN; PEPTIDOLEUKOTRIENE; PROSTANOID; PURINE NUCLEOSIDE; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SOMATOMEDIN C; THEOPHYLLINE; VASCULOTROPIN; XANTHINE DERIVATIVE;

ASTHMA; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFICACY; EOSINOPHILIA; GENE CONTROL; HUMAN; IMMUNOGLOBULIN PRODUCTION; LUNG LAVAGE; MAST CELL; MEDIATOR RELEASE; MUCUS SECRETION; NONHUMAN; NUCLEIC ACID METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TISSUE INJURY;

EID: 0036083974     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00386.2001     Document Type: Short Survey

References (26)

1. Exercise, methacholine and adenosine 5′-monophosphate challenges in children with asthma: Relation to severity of the disease
2. Gene expression profiling in inflammatory airway disease associated with elevated adenosine
3. Isolated bronchi from asthmatics are hyperresponsive to adenosine which apparently acts indirectly by liberation of leukotrienes and histamine
4. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation and airway obstruction
5. The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5′-monophosphate-provoked bronchoconstriction: Implications for the mechanisms of action of xanthine derivatives in asthma
6. The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects
7. Adenosine induced bronchoconstriction in asthma: Antagonism by inhaled theophylline
8. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma
9. 2B receptors: A novel therapeutic target in asthma?
10. Repeated exposure of asthmatic airways to inhaled adenosine 5′-monophosphate attenuates bronchoconstriction provoked by exercise
11. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation
12. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype
13. Adenosine receptor ligands: Potential as therapeutic agents in asthma and COPD
14. Epithelial-mesenchymal interactions in the pathogenesis of asthma
15. 2-purinoceptor mediated mechanism
16. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma
17. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells
18. Adenosine potentiates mediator release from human lung mast cells
19. Unbalanced research
20. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5′-monophosphate in nonatopic asthma
21. Adenosine bronchoprovocation: A promising marker of allergic inflammation in asthma?
22. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma
23. Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma
24. The role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma
25. Airway inflammation and hyperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease
26. Adult presentation of adenosine deaminase deficiency